TSPAN32
geneOn this page
Summary
TSPAN32 (tetraspanin 32, HGNC:13410) is a protein-coding gene on chromosome 11p15.5, encoding Tetraspanin-32 (Q96QS1).
This gene, which is a member of the tetraspanin superfamily, is one of several tumor-suppressing subtransferable fragments located in the imprinted gene domain of chromosome 11p15.5, an important tumor-suppressor gene region. Alterations in this region have been associated with Beckwith-Wiedemann syndrome, Wilms tumor, rhabdomyosarcoma, adrenocortical carcinoma, and lung, ovarian and breast cancers. This gene is located among several imprinted genes; however, this gene, as well as the tumor-suppressing subchromosomal transferable fragment 4, escapes imprinting. This gene may play a role in malignancies and diseases that involve this region, and it is also involved in hematopoietic cell function. Alternatively spliced transcript variants have been described, but their biological validity has not been determined.
Source: NCBI Gene 10077 — RefSeq curated summary.
At a glance
- GWAS associations: 20
- Clinical variants (ClinVar): 61 total
- MANE Select transcript:
NM_139022
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13410 |
| Approved symbol | TSPAN32 |
| Name | tetraspanin 32 |
| Location | 11p15.5 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000064201 |
| Ensembl biotype | protein_coding |
| OMIM | 603853 |
| Entrez | 10077 |
Gene structure
Transcript identifiers
Ensembl transcripts: 20 — 8 protein_coding, 5 retained_intron, 4 protein_coding_CDS_not_defined, 3 nonsense_mediated_decay
ENST00000182290, ENST00000339046, ENST00000381117, ENST00000381121, ENST00000437313, ENST00000446063, ENST00000451520, ENST00000461200, ENST00000479508, ENST00000483227, ENST00000484104, ENST00000484523, ENST00000486011, ENST00000493924, ENST00000493948, ENST00000498313, ENST00000612299, ENST00000855795, ENST00000855796, ENST00000961152
RefSeq mRNA: 1 — MANE Select: NM_139022
NM_139022
CCDS: CCDS7733
Canonical transcript exons
ENST00000182290 — 10 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000000305 | 2317863 | 2318204 |
| ENSE00003462246 | 2317344 | 2317525 |
| ENSE00003480862 | 2316576 | 2316667 |
| ENSE00003484317 | 2308736 | 2308810 |
| ENSE00003488994 | 2302844 | 2302958 |
| ENSE00003515738 | 2304107 | 2304204 |
| ENSE00003523091 | 2313654 | 2313755 |
| ENSE00003560711 | 2314485 | 2314571 |
| ENSE00003639432 | 2316229 | 2316312 |
| ENSE00003899459 | 2302013 | 2302215 |
Expression profiles
Bgee: expression breadth ubiquitous, 166 present calls, max score 98.56.
FANTOM5 (CAGE): breadth broad, TPM avg 3.0892 / max 201.6748, expressed in 326 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 112677 | 1.6206 | 245 |
| 112676 | 1.1788 | 163 |
| 112679 | 0.2723 | 85 |
| 112678 | 0.0176 | 8 |
Top tissues by expression
275 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| granulocyte | CL:0000094 | 98.56 | gold quality |
| apex of heart | UBERON:0002098 | 95.62 | gold quality |
| monocyte | CL:0000576 | 93.82 | gold quality |
| mononuclear cell | CL:0000842 | 93.54 | gold quality |
| leukocyte | CL:0000738 | 93.49 | gold quality |
| blood | UBERON:0000178 | 89.98 | gold quality |
| spleen | UBERON:0002106 | 86.42 | gold quality |
| bone marrow cell | CL:0002092 | 85.32 | gold quality |
| bone marrow | UBERON:0002371 | 85.27 | gold quality |
| heart left ventricle | UBERON:0002084 | 85.11 | gold quality |
| cardiac ventricle | UBERON:0002082 | 84.81 | gold quality |
| right atrium auricular region | UBERON:0006631 | 84.46 | gold quality |
| lymph node | UBERON:0000029 | 82.69 | gold quality |
| cardiac atrium | UBERON:0002081 | 81.89 | gold quality |
| triceps brachii | UBERON:0001509 | 81.82 | gold quality |
| gluteal muscle | UBERON:0002000 | 81.41 | gold quality |
| heart | UBERON:0000948 | 81.36 | gold quality |
| trabecular bone tissue | UBERON:0002483 | 80.48 | silver quality |
| upper lobe of left lung | UBERON:0008952 | 78.34 | gold quality |
| vermiform appendix | UBERON:0001154 | 78.08 | gold quality |
| gall bladder | UBERON:0002110 | 77.04 | gold quality |
| right lung | UBERON:0002167 | 76.88 | gold quality |
| upper lobe of lung | UBERON:0008948 | 76.87 | gold quality |
| tibialis anterior | UBERON:0001385 | 74.92 | silver quality |
| parotid gland | UBERON:0001831 | 74.82 | gold quality |
| body of uterus | UBERON:0009853 | 74.79 | gold quality |
| caecum | UBERON:0001153 | 74.75 | gold quality |
| mucosa of stomach | UBERON:0001199 | 73.37 | gold quality |
| right coronary artery | UBERON:0001625 | 73.18 | gold quality |
| colonic epithelium | UBERON:0000397 | 73.17 | gold quality |
Single-cell (SCXA)
Detected in 4 experiment(s), a significant marker in 4.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-112 | yes | 35.80 |
| E-HCAD-10 | yes | 16.15 |
| E-MTAB-9067 | yes | 11.69 |
| E-ANND-3 | yes | 4.44 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 3)
- In the absence of both CD37 and Tssc6, immune function is further altered when compared with CD37- or Tssc6-deficient transgenic mice, demonstrating a complementary role for these two molecules in cellular immunity. (PMID:20709950)
- TSPAN32 mRNA level is significantly reduced in CD4 T cells of multiple sclerosis patients. (PMID:31487788)
- Altered Expression of TSPAN32 during B Cell Activation and Systemic Lupus Erythematosus. (PMID:34207245)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Tspan32 | ENSMUSG00000000244 |
| rattus_norvegicus | Tspan32 | ENSRNOG00000026039 |
Paralogs (32): TSPAN6 (ENSG00000000003), CD9 (ENSG00000010278), TSPAN9 (ENSG00000011105), TSPAN17 (ENSG00000048140), CD82 (ENSG00000085117), TSPAN15 (ENSG00000099282), CD37 (ENSG00000104894), UPK1A (ENSG00000105668), TSPAN12 (ENSG00000106025), TSPAN13 (ENSG00000106537), TSPAN14 (ENSG00000108219), CD81 (ENSG00000110651), TSPAN11 (ENSG00000110900), PRPH2 (ENSG00000112619), UPK1B (ENSG00000114638), TSPAN1 (ENSG00000117472), TSPAN8 (ENSG00000127324), TSPAN16 (ENSG00000130167), TSPAN2 (ENSG00000134198), CD63 (ENSG00000135404), TSPAN31 (ENSG00000135452), TSPAN3 (ENSG00000140391), CD53 (ENSG00000143119), ROM1 (ENSG00000149489), TSPAN7 (ENSG00000156298), TSPAN18 (ENSG00000157570), TSPAN33 (ENSG00000158457), TSPAN5 (ENSG00000168785), CD151 (ENSG00000177697), TSPAN10 (ENSG00000182612), TSPAN4 (ENSG00000214063), TSPAN19 (ENSG00000231738)
Protein
Protein identifiers
Tetraspanin-32 — Q96QS1 (reviewed: Q96QS1)
Alternative names: Protein Phemx
All UniProt accessions (5): Q96QS1, D3YTD1, F8WB10, F8WCN6, G3XAG6
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Membrane.
Tissue specificity. Expressed ubiquitously at low levels. High levels of expression are confined to hematopoietic tissues including peripheral blood leukocytes, thymus and spleen.
Miscellaneous. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.
Similarity. Belongs to the tetraspanin (TM4SF) family.
Isoforms (5)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q96QS1-1 | 1 | yes |
| Q96QS1-2 | 2 | |
| Q96QS1-3 | 3 | |
| Q96QS1-4 | 4 | |
| Q96QS1-5 | 5 |
RefSeq proteins (1): NP_620591* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR008952 | Tetraspanin_EC2_sf | Homologous_superfamily |
| IPR018499 | Tetraspanin/Peripherin | Family |
| IPR042782 | PHEMX_LEL | Domain |
Pfam: PF00335
UniProt features (12 total): splice variant 7, transmembrane region 4, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96QS1-F1 | 72.74 | 0.37 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 241 (showing top):
GOBP_REGULATION_OF_CELL_ACTIVATION, GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_GROWTH_FACTOR_STIMULUS, GOBP_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_SIGNALING_PATHWAY, GOBP_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS, GOBP_PLATELET_ACTIVATION, GOCC_CELL_SURFACE, GOBP_CELL_CELL_SIGNALING, GOBP_WOUND_HEALING, GOBP_CELL_CELL_ADHESION, GOBP_NEGATIVE_REGULATION_OF_MULTICELLULAR_ORGANISMAL_PROCESS, GOBP_DEFENSE_RESPONSE_TO_OTHER_ORGANISM, GOBP_MYELOID_LEUKOCYTE_ACTIVATION, BLALOCK_ALZHEIMERS_DISEASE_UP, GOBP_RESPONSE_TO_PROTOZOAN, GATA6_01
GO Biological Process (14): cytoskeleton organization (GO:0007010), integrin-mediated signaling pathway (GO:0007229), cell-cell signaling (GO:0007267), negative regulation of myeloid dendritic cell activation (GO:0030886), T cell proliferation (GO:0042098), negative regulation of T cell proliferation (GO:0042130), defense response to protozoan (GO:0042832), regulation of defense response to virus (GO:0050688), platelet aggregation (GO:0070527), regulation of vascular endothelial growth factor signaling pathway (GO:1900746), cell communication (GO:0007154), blood coagulation (GO:0007596), hemostasis (GO:0007599), signaling (GO:0023052)
GO Molecular Function (0):
GO Cellular Component (4): plasma membrane (GO:0005886), cell surface (GO:0009986), integrin alphaIIb-beta3 complex (GO:0070442), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| organelle organization | 1 |
| cell surface receptor signaling pathway | 1 |
| cell communication | 1 |
| signaling | 1 |
| myeloid dendritic cell activation | 1 |
| negative regulation of leukocyte activation | 1 |
| regulation of myeloid dendritic cell activation | 1 |
| T cell activation | 1 |
| lymphocyte proliferation | 1 |
| T cell proliferation | 1 |
| regulation of T cell proliferation | 1 |
| negative regulation of lymphocyte proliferation | 1 |
| negative regulation of T cell activation | 1 |
| response to protozoan | 1 |
| defense response to other organism | 1 |
| regulation of response to biotic stimulus | 1 |
| regulation of defense response | 1 |
| regulation of response to external stimulus | 1 |
| defense response to virus | 1 |
| platelet activation | 1 |
| homotypic cell-cell adhesion | 1 |
| regulation of signal transduction | 1 |
| vascular endothelial growth factor signaling pathway | 1 |
| regulation of cellular response to vascular endothelial growth factor stimulus | 1 |
| cellular process | 1 |
| hemostasis | 1 |
| wound healing | 1 |
| coagulation | 1 |
| regulation of body fluid levels | 1 |
| regulation of biological process | 1 |
| membrane | 1 |
| cell periphery | 1 |
| integrin complex | 1 |
Protein interactions and networks
STRING
988 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TSPAN32 | TSSC4 | Q9Y5U2 | 927 |
| TSPAN32 | CD63 | P08962 | 800 |
| TSPAN32 | CD151 | P48509 | 799 |
| TSPAN32 | CD9 | P21926 | 790 |
| TSPAN32 | PHLDA2 | Q53GA4 | 739 |
| TSPAN32 | C11orf21 | Q9P2W6 | 720 |
| TSPAN32 | TSPAN9 | O75954 | 715 |
| TSPAN32 | CD81 | P18582 | 704 |
| TSPAN32 | SLC67A1 | Q96BI1 | 669 |
| TSPAN32 | B4E171 | B4E171 | 667 |
| TSPAN32 | CD37 | P11049 | 630 |
| TSPAN32 | ASCL2 | Q99929 | 628 |
| TSPAN32 | CD2 | P06729 | 598 |
| TSPAN32 | TSPAN7 | P41732 | 582 |
| TSPAN32 | CD53 | P19397 | 577 |
IntAct
0 interactions, top by confidence:
BioGRID (1): TSPAN32 (Positive Genetic)
ESM2 similar proteins: A5D8T8, A6QLH5, E9PZ19, O18796, O43414, O60242, O70512, O75462, O75900, O88272, O88507, O88676, O95633, P08887, P0C7M8, P0C7M9, P26992, P39905, P78539, Q08334, Q08406, Q0V881, Q0ZCA7, Q1LZB9, Q2HJ53, Q2KIS7, Q2TBM7, Q4V892, Q5SQ64, Q62225, Q63769, Q642A6, Q6IA17, Q6P1D5, Q6PCB0, Q6UXF7, Q71DR4, Q7TPB4, Q7TSQ1, Q80ZF8
Diamond homologs: Q96QS1, Q9JHH2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
61 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 49 |
| Likely benign | 4 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1899 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:2302954:ATGGG:A | donor_gain | 1.0000 |
| 11:2302956:GGG:G | donor_gain | 1.0000 |
| 11:2302957:GG:G | donor_gain | 1.0000 |
| 11:2302957:GGG:G | donor_gain | 1.0000 |
| 11:2302958:GG:G | donor_gain | 1.0000 |
| 11:2302959:G:GG | donor_gain | 1.0000 |
| 11:2304202:GGG:G | donor_gain | 1.0000 |
| 11:2304203:GGG:G | donor_gain | 1.0000 |
| 11:2302842:A:AG | acceptor_gain | 0.9900 |
| 11:2302843:G:GG | acceptor_gain | 0.9900 |
| 11:2302843:GCT:G | acceptor_gain | 0.9900 |
| 11:2302955:TGGG:T | donor_gain | 0.9900 |
| 11:2302956:GGGG:G | donor_gain | 0.9900 |
| 11:2304105:A:AG | acceptor_gain | 0.9900 |
| 11:2304106:G:GG | acceptor_gain | 0.9900 |
| 11:2313648:GTGCA:G | acceptor_loss | 0.9900 |
| 11:2313650:GCAGG:G | acceptor_loss | 0.9900 |
| 11:2313651:CAGGT:C | acceptor_loss | 0.9900 |
| 11:2313652:AGGT:A | acceptor_gain | 0.9900 |
| 11:2313653:GGTG:G | acceptor_gain | 0.9900 |
| 11:2313750:G:GT | donor_gain | 0.9900 |
| 11:2314483:A:AG | acceptor_gain | 0.9900 |
| 11:2314484:G:GA | acceptor_gain | 0.9900 |
| 11:2314551:G:GT | donor_gain | 0.9900 |
| 11:2302066:G:GG | donor_gain | 0.9800 |
| 11:2302108:G:GT | donor_gain | 0.9800 |
| 11:2304101:A:AG | acceptor_gain | 0.9800 |
| 11:2304203:GG:G | donor_gain | 0.9800 |
| 11:2304204:GG:G | donor_gain | 0.9800 |
| 11:2313652:A:AG | acceptor_gain | 0.9800 |
AlphaMissense
2057 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:2304160:A:C | S79R | 0.978 |
| 11:2304162:C:A | S79R | 0.978 |
| 11:2304162:C:G | S79R | 0.978 |
| 11:2316594:A:C | S216R | 0.976 |
| 11:2316596:C:A | S216R | 0.976 |
| 11:2316596:C:G | S216R | 0.976 |
| 11:2308745:T:C | C97R | 0.974 |
| 11:2314502:G:C | K158N | 0.971 |
| 11:2314502:G:T | K158N | 0.971 |
| 11:2304148:G:A | G75R | 0.967 |
| 11:2304148:G:C | G75R | 0.967 |
| 11:2316234:C:G | C183W | 0.967 |
| 11:2313678:T:G | Y127D | 0.966 |
| 11:2308739:T:C | F95L | 0.964 |
| 11:2308741:C:A | F95L | 0.964 |
| 11:2308741:C:G | F95L | 0.964 |
| 11:2302182:A:C | K11N | 0.963 |
| 11:2302182:A:T | K11N | 0.963 |
| 11:2314491:T:C | C155R | 0.961 |
| 11:2314491:T:A | C155S | 0.959 |
| 11:2314492:G:C | C155S | 0.959 |
| 11:2316233:G:A | C183Y | 0.959 |
| 11:2302850:G:C | G25R | 0.955 |
| 11:2314485:T:C | F153L | 0.953 |
| 11:2314487:T:A | F153L | 0.953 |
| 11:2314487:T:G | F153L | 0.953 |
| 11:2304124:A:C | S67R | 0.952 |
| 11:2304126:C:A | S67R | 0.952 |
| 11:2304126:C:G | S67R | 0.952 |
| 11:2316232:T:C | C183R | 0.952 |
dbSNP variants (sampled 300 via entrez): RS1000061442 (11:2309549 G>C), RS1000126797 (11:2313864 G>A,T), RS1000249125 (11:2318351 G>C), RS1000318598 (11:2304502 T>G), RS1000503694 (11:2300430 TG>T), RS1000574413 (11:2312954 T>C), RS1000709913 (11:2305203 C>A,T), RS1001214626 (11:2309094 C>A,G,T), RS1001574590 (11:2317824 T>C,G), RS1001905291 (11:2311836 C>T), RS1001908658 (11:2316832 G>A), RS1002630857 (11:2307256 A>C), RS1002788528 (11:2306137 C>G), RS1002825660 (11:2303237 C>A,T), RS1002836093 (11:2304174 C>A,T)
Disease associations
OMIM: gene MIM:603853 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
20 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002073_2 | Chronic lymphocytic leukemia | 2.000000e-10 |
| GCST002299_14 | Chronic lymphocytic leukemia | 3.000000e-06 |
| GCST004146_15 | Chronic lymphocytic leukemia | 5.000000e-11 |
| GCST009131_17 | Systemic sclerosis | 3.000000e-10 |
| GCST009181_12 | Cuneus cortex volume | 6.000000e-06 |
| GCST009196_5 | Pericalcarine cortex volume | 1.000000e-06 |
| GCST010083_113 | Hemoglobin levels | 2.000000e-08 |
| GCST010725_20 | Malaria | 4.000000e-69 |
| GCST010725_33 | Malaria | 2.000000e-67 |
| GCST010725_51 | Malaria | 1.000000e-55 |
| GCST012277_3 | Clostridioides difficle infection | 3.000000e-07 |
| GCST90002384_277 | Hemoglobin | 3.000000e-10 |
| GCST90002389_459 | Lymphocyte percentage of white cells | 5.000000e-12 |
| GCST90002391_194 | Mean corpuscular hemoglobin concentration | 5.000000e-11 |
| GCST90002393_348 | Monocyte count | 1.000000e-11 |
| GCST90002394_463 | Monocyte percentage of white cells | 3.000000e-11 |
| GCST90002396_450 | Mean reticulocyte volume | 2.000000e-16 |
| GCST90002398_191 | Neutrophil count | 8.000000e-11 |
| GCST90002404_503 | Red cell distribution width | 1.000000e-11 |
| GCST90002405_270 | Reticulocyte count | 1.000000e-11 |
EFO canonical traits (10, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004509 | hemoglobin measurement |
| EFO:0009130 | clostridium difficile infection |
| EFO:0007993 | lymphocyte percentage of leukocytes |
| EFO:0004528 | mean corpuscular hemoglobin concentration |
| EFO:0005091 | monocyte count |
| EFO:0007989 | monocyte percentage of leukocytes |
| EFO:0010701 | mean reticulocyte volume |
| EFO:0004833 | neutrophil count |
| EFO:0009188 | Red cell distribution width |
| EFO:0007986 | reticulocyte count |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
13 total (human), top 13 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| (+)-JQ1 compound | decreases expression | 2 |
| GSK-J4 | decreases expression | 1 |
| mivebresib | decreases expression | 1 |
| beta-lapachone | decreases expression | 1 |
| sodium arsenite | affects methylation | 1 |
| cobaltous chloride | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| Acetaminophen | increases expression | 1 |
| Azacitidine | decreases expression | 1 |
| Benzo(a)pyrene | decreases methylation, increases methylation | 1 |
| Triclosan | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Antirheumatic Agents | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): B-cell chronic lymphocytic leukemia, malaria, systemic sclerosis